Grifols, S.A. GRFS
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -13.37%
- 1 year
- -11.57%
- Open
- 8.10
- Prev close
- 8.04
- Mkt cap
- 5.51B
- Vol
- 803.38K
- Avg vol
- 530.76K
- EPS
- 0.77
- P/E
- 10.52
- Div yield
- 1.32%
More statistics
- Low
- 8.05
- High
- 8.25
- Forward P/E
- 6.08
- Beta
- 1.20
- Short ratio
- 11.06
- Inst. own
- 57.27%
- Dividend
- 0.11
- Ex-div date
- Jul 1, 2026
- Earnings
- Nov 2, 2026
- 50-d avg
- 7.59
- 200-d avg
- 8.00
- 1y target
- 10.37
News
2 weeks ago defenseworld.net
Grifols, S.A. (NASDAQ:GRFS) Sees Significant Increase in Short Interest
Grifols, S.A. (NASDAQ: GRFS - Get Free Report) saw a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 7,001,241 shares, a growth…
1 month ago defenseworld.net
Head to Head Analysis: Creative Medical Technology (NASDAQ:CELZ) versus Grifols (NASDAQ:GRFS)
Grifols (NASDAQ: GRFS - Get Free Report) and Creative Medical Technology (NASDAQ: CELZ - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two…
1 month ago zacks.com
GRFS vs. SDZNY: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two stocks presents investors with the…
1 month ago reuters.com
Grifols says Canada plasma license suspension has no impact
Spanish drugmaker Grifols said Health Canada's decision to suspend its license to collect plasma at its Taylor Avenue facility in Winnipeg had no impact on operations.
1 month ago seekingalpha.com
Grifols: Better Plasma Economics Can Unlock A Discounted Equity
Grifols is shifting to regional plasma sourcing, aiming for durable cash generation over headline catalysts like a U.S. listing or refinancing. I see improved cash flow as contingent on better…
1 month ago defenseworld.net
Analyzing Gilead Sciences (NASDAQ:GILD) & Grifols (NASDAQ:GRFS)
Gilead Sciences (NASDAQ: GILD - Get Free Report) and Grifols (NASDAQ: GRFS - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies…
1 month ago zacks.com
GRFS or SDZNY: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Drugs stocks are likely familiar with Grifols (GRFS) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two companies is the best option for those looking…
2 months ago seekingalpha.com
Oakmark International Small Cap Strategy Q2 2026 Portfolio Update
The portfolio's return was 5.34% (net) for the reporting period. We initiated the following positions: Birkenstock Holding, Dormakaba, Hiab, Reply, SATS Ltd., and Scout24. We eliminated the following…
2 months ago globenewswire.com
Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency
BARCELONA, Spain, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today announced the…
3 months ago seekingalpha.com
Grifols, S.A. (GIKLY) Q2 2026 Earnings Call Transcript
Grifols, S.A. (GIKLY) Q2 2026 Earnings Call Transcript
3 months ago marketbeat.com
Grifols Q2 Earnings Call Highlights
Grifols NASDAQ: GRFS said its second-quarter and first-half results kept the plasma-derived medicines company on track to meet its 2026 objectives, supported by continued growth in immunoglobulins,…
-
3 months ago benzinga.com
Grifols Doses First Participants In Two Separate Phase 3 Studies To Expand U.S. Labels For Its GAMUNEX-C, XEMBIFY Subcutaneous Immunoglobulin
Grifols ((MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today announced that the first patients have been dosed in two separate Phase…
3 months ago globenewswire.com
Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins
BARCELONA, Spain, July 16, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today announced that the…
4 months ago seekingalpha.com
Grifols: Operational Recovery And Balance Sheet Improvement Support A Return To Buy (Rating Upgrade)
First-quarter results were broadly in line with expectations, supported by strong growth in the Biopharma division, particularly immunoglobulins, where products such as Gamunex and Yimmugo continue…
4 months ago globenewswire.com
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
BARCELONA, Spain, June 15, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today announced the U.S.…
5 months ago seekingalpha.com
Grifols: Plasma Self-Sufficiency Is The Mispriced Catalyst
Grifols is transitioning from a leveraged recovery story to a strategic plasma infrastructure leader with global scale and supply security advantages. GRFS trades at a significant valuation…
5 months ago seekingalpha.com
Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript
Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript
-
5 months ago benzinga.com
Grifols Q1 Revenue €1.7 Billion Down From €1.786 Billion YoY
https://www.grifols.com/en/view-news/-/news/grifols-increases-q1-2026-revenues-by-3-3-to-1-7billion-and-net-profit-21-9-to-73-million
6 months ago defenseworld.net
Aldeyra Therapeutics (NASDAQ:ALDX) and Grifols (NASDAQ:GRFS) Head to Head Comparison
Aldeyra Therapeutics (NASDAQ: ALDX - Get Free Report) and Grifols (NASDAQ: GRFS - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses…
6 months ago benzinga.com
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures lower on Thursday with Applied Digital Corp. (APLD) falling sharply in pre-market trading after beating analyst estimates.
-
7 months ago benzinga.com
'Grifols' Canadian License Restricted After Plasma Donor Deaths' - Bloomberg
https://www.bloomberg.com/news/articles/2026-04-02/grifols-canadian-license-restricted-after-plasma-donor-deaths
7 months ago globenewswire.com
Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates
OTTAWA, March 30, 2026 (GLOBE NEWSWIRE) -- Proponents of public universal health care across Canada are calling for the closure of Grifols facilities in the wake of two deaths in Winnipeg of people…
7 months ago reuters.com
Grifols approves IPO of its US biopharma business
Healthcare company Grifols said on Tuesday it has approved a U.S. initial public offering of its U.S. biopharma business.
-
7 months ago benzinga.com
Grifols' Chronos-PD Study Demonstrates That Biological Changes In Individuals With Parkinson's Disease Occur More Than A Decade Before Clinical Diagnosis, With Potential Future Implications For Early Detection And Intervention
Chronos‑PD shows that biological changes associated with Parkinson's disease (PD) can emerge up to 12 years before clinical diagnosis Uncovered reproducible early molecular signals and distinct…
7 months ago globenewswire.com
Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease
BARCELONA, Spain, March 17, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today shared…
-
8 months ago benzinga.com
Grifols Expects Reaching Free Cash Flow Pre-M&A Pre-Dividends Of €500M-575M; 2027 Milestones Unchanged; 2026 Adjusted EBITDA Margin Of Over 25%
https://www.grifols.com/en/view-news/-/news/grifols-reports-revenues-of-eur-7524m-up-7-and-more-than-doubles-group-profit-to-eur-402m
-
10 months ago benzinga.com
CORRECTION: JP Morgan Maintains Neutral on Grifols, Maintains $10 Price Target (Price Target Updated - Rating Originally Published on 8th Dec)
CORRECTION: JP Morgan analyst Richard Vosser maintains Grifols (NASDAQ:GRFS) with a Neutral and maintains $10 price target.
-
10 months ago benzinga.com
JP Morgan Maintains Neutral on Grifols, Lowers Price Target to $10
JP Morgan analyst James Gordon maintains Grifols (NASDAQ:GRFS) with a Neutral and lowers the price target from $10.3 to $10.
1 year ago benzinga.com
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
-
1 year ago benzinga.com
JP Morgan Maintains Neutral on Grifols, Raises Price Target to $10.3
JP Morgan analyst James Gordon maintains Grifols (NASDAQ:GRFS) with a Neutral and raises the price target from $7.6 to $10.3.
-
1 year ago benzinga.com
Grifols Q1 Revenue €1.786 Billion; Adjusted EBITDA €400 Million; Q1 Net Income €60 Million; Confirms 2025 Guidance; Says On Track To Launch Fibrinogen In Europe In Q4'25 And In The U.S. In H1'26, Following FDA Approval; Expects To Share Greater Detail In 2025 Due To Impact Of Inflation Reduction Act On Its Financial Results
https://www.cnmv.es/webservices/verdocumento/ver?t=%7Bb75ee6db-df80-49ee-bf19-dfb0c0eed666%7D
1 year ago benzinga.com
Why Sportsman's Warehouse Shares Are Trading Higher By Around 39%; Here Are 20 Stocks Moving Premarket
Why Sportsman's Warehouse Shares Are Trading Higher By Around 39%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
Grifols Chairman Thomas Glanzmann To Retire; To Be Succeeded Ann-Catherine Berner
https://www.grifols.com/en/view-news/-/news/thomas-glanzmann-to-retire-as-grifols-chairman-and-will-be-succeeded-by-board-member-anne-catherine-berner
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
1 year ago benzinga.com
Dell, HP, CrowdStrike, 3D Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Dell, HP, CrowdStrike, 3D Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
-
2 years ago benzinga.com
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.
-
2 years ago benzinga.com
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.
-
2 years ago benzinga.com
Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday.
-
2 years ago benzinga.com
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
-
2 years ago benzinga.com
Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Wipro Limited (NYSE: WIT) rose sharply during Friday’s session after the company reported third-quarter financial results, issued guidance and declared an interim dividend. Wipro shares…
-
2 years ago benzinga.com
Why VCI Global Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
Shares of VCI Global Limited (NASDAQ: VCIG) fell sharply in pre-market trading after the company announced pricing of $2.75 million public offering. VCI Global shares tumbled 29.5% to $1.10 in…
-
2 years ago benzinga.com
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.
-
2 years ago benzinga.com
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update.
-
3 years ago benzinga.com
CPI Sent Market Surging - But Some Stocks Took A Hit: Spotlight On Top Gainers And Hard-Hit Decliners
The market is trading higher on Wednesday after the Labor Department reported the latest Consumer Price Index figure for the month of March. While most stocks are trading higher alongside the major…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 446 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 930 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 361 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 400 companies set new 52-week lows.